IRIS Accounts Production v23.3.1.45 03457163 Board of Directors 1.11.22 31.10.23 31.10.23 false true false false true false Ordinary shares 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh034571632022-10-31034571632023-10-31034571632022-11-012023-10-31034571632021-10-31034571632021-11-012022-10-31034571632022-10-3103457163ns14:PoundSterlingns10:Original2022-11-012023-10-3103457163ns10:Originalns10:Director12022-11-012023-10-3103457163ns10:Original2022-11-012023-10-3103457163ns10:Original2023-10-3103457163ns10:Originalns10:PrivateLimitedCompanyLtd2022-11-012023-10-3103457163ns10:Originalns10:SmallEntities2022-11-012023-10-3103457163ns10:Originalns10:AuditExempt-NoAccountantsReport2022-11-012023-10-3103457163ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-11-012023-10-3103457163ns10:SmallCompaniesRegimeForAccountsns10:Original2022-11-012023-10-3103457163ns10:Originalns10:FullAccounts2022-11-012023-10-3103457163ns10:Originalns10:OrdinaryShareClass12022-11-012023-10-3103457163ns10:Originalns10:Director22022-11-012023-10-3103457163ns10:CompanySecretary1ns10:Original2022-11-012023-10-3103457163ns10:Originalns10:RegisteredOffice2022-11-012023-10-3103457163ns10:Original2022-10-3103457163ns10:Originalns5:CurrentFinancialInstruments2023-10-3103457163ns10:Originalns5:CurrentFinancialInstruments2022-10-3103457163ns5:ShareCapitalns10:Original2023-10-3103457163ns5:ShareCapitalns10:Original2022-10-3103457163ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-10-3103457163ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-10-3103457163ns10:Originalns5:FurnitureFittings2022-11-012023-10-3103457163ns10:Original2021-11-012022-10-3103457163ns10:Originalns5:FurnitureFittings2022-10-3103457163ns10:Originalns5:FurnitureFittings2023-10-3103457163ns10:Originalns5:FurnitureFittings2022-10-3103457163ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-10-3103457163ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-10-3103457163ns10:Originalns10:OrdinaryShareClass12023-10-3103457163ns10:Original1ns10:Director12022-10-3103457163ns10:Original1ns10:Director12021-10-3103457163ns10:Original1ns10:Director12022-11-012023-10-3103457163ns10:Original1ns10:Director12021-11-012022-10-3103457163ns10:Original1ns10:Director12023-10-3103457163ns10:Original1ns10:Director12022-10-3103457163ns10:Originalns10:Director222022-10-3103457163ns10:Originalns10:Director222021-10-3103457163ns10:Originalns10:Director222022-11-012023-10-3103457163ns10:Originalns10:Director222021-11-012022-10-3103457163ns10:Originalns10:Director222023-10-3103457163ns10:Originalns10:Director222022-10-31
















MATERIA MEDICA LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 OCTOBER 2023






MATERIA MEDICA LIMITED (REGISTERED NUMBER: 03457163)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2023










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


MATERIA MEDICA LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 OCTOBER 2023







DIRECTORS: R J Bradley
Mrs J A Bradley





SECRETARY: Mrs J A Bradley





REGISTERED OFFICE: Moors House
11 South Hawksworth Street
Ilkley
West Yorkshire
LS29 9DX





REGISTERED NUMBER: 03457163





ACCOUNTANTS: Wilkinson and Partners
Moors House
11 South Hawksworth Street
Ilkley
West Yorkshire
LS29 9DX

MATERIA MEDICA LIMITED (REGISTERED NUMBER: 03457163)

BALANCE SHEET
31 OCTOBER 2023

31.10.23 31.10.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 425 837

CURRENT ASSETS
Debtors 5 19,458 27,752
Cash at bank 53,583 57,676
73,041 85,428
CREDITORS
Amounts falling due within one year 6 10,705 18,258
NET CURRENT ASSETS 62,336 67,170
TOTAL ASSETS LESS CURRENT LIABILITIES 62,761 68,007

PROVISIONS FOR LIABILITIES 7 151 159
NET ASSETS 62,610 67,848

CAPITAL AND RESERVES
Called up share capital 8 100 100
Retained earnings 62,510 67,748
SHAREHOLDERS' FUNDS 62,610 67,848

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

MATERIA MEDICA LIMITED (REGISTERED NUMBER: 03457163)

BALANCE SHEET - continued
31 OCTOBER 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 12 December 2023 and were signed on its behalf by:





R J Bradley - Director


MATERIA MEDICA LIMITED (REGISTERED NUMBER: 03457163)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2023


1. STATUTORY INFORMATION

Materia Medica Limited is a private company, limited by shares , registered in Not specified/Other. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents net invoiced sales of goods and services, excluding value added tax, except in respect of service contracts where turnover is recognised when the company obtains the right to consideration.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 33% on cost and 20% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 2 ) .

MATERIA MEDICA LIMITED (REGISTERED NUMBER: 03457163)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 OCTOBER 2023


4. TANGIBLE FIXED ASSETS
Fixtures
and
fittings
£   
COST
At 1 November 2022
and 31 October 2023 1,249
DEPRECIATION
At 1 November 2022 412
Charge for year 412
At 31 October 2023 824
NET BOOK VALUE
At 31 October 2023 425
At 31 October 2022 837

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.10.23 31.10.22
£    £   
Trade debtors - 27,751
Directors' current accounts 19,458 -
VAT - 1
19,458 27,752

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.10.23 31.10.22
£    £   
Bank loans and overdrafts 323 -
Corporation tax 9,187 10,597
Social security and other taxes - 5,314
Directors' current accounts - 1,197
Accruals 1,195 1,150
10,705 18,258

7. PROVISIONS FOR LIABILITIES

The movement in the deferred tax provision is wholly attributable to accelerated capital allowances.

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.10.23 31.10.22
value: £    £   
100 Ordinary shares £1 100 100

MATERIA MEDICA LIMITED (REGISTERED NUMBER: 03457163)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 OCTOBER 2023


9. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 October 2023 and 31 October 2022:

31.10.23 31.10.22
£    £   
R J Bradley
Balance outstanding at start of year (798 ) (4,351 )
Amounts advanced 29,005 32,113
Amounts repaid (18,480 ) (28,560 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 9,727 (798 )

Mrs J A Bradley
Balance outstanding at start of year (399 ) (4,034 )
Amounts advanced 35,650 43,075
Amounts repaid (25,520 ) (39,440 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 9,731 (399 )